Metagenomi展示了AI发现的CRISPR工具CAST, 很有希望的精确基因疾病治疗。 Metagenomi unveils AI-discovered CRISPR tool CAST, promising precise genetic disease treatments.

基因医学公司Metegenomi出版了《自然通讯》研究报告,详细介绍了CRISPR的一个新工具,即CAST,可以精确地将大型基因纳入人体细胞。 Metagenomi, a genetic medicine company, published a study in Nature Communications detailing a new CRISPR tool called CAST, which can integrate large genes into human cells with precision. 使用人工智能发现的这一技术,可以帮助治疗细胞纤维化和杜尚症肌肉萎缩等遗传疾病。 This technology, discovered using AI, could help treat genetic diseases like cystic fibrosis and Duchenne muscular dystrophy. 该系统利用单一的MRNA简化基因输送,使公司更接近于临床应用基因疗法。 The system simplifies gene delivery using a single mRNA, bringing the company closer to clinical applications for genetic therapies.